Abstract. ATP and hydrolysis products of ATP like adenosine regulate the chemotaxis of neutrophils by activating purinoceptors and adenosine receptors. The present study was designed to examine exogenous ATP, activation of purinoceptors, and activation of A 3 adenosine receptor as key steps in the signal cascades that control cell orientation and migration of rat neutrophils. One or more of those steps might be potential therapeutic targets for treatment of inflammatory diseases. The chemotaxis of rat neutrophils was stimulated with N-formyl-methionyl-leucyl-phenylalanine (fMLP) and measured with an EZ-TAXIScan apparatus. The effects of apyrase, exogenous ATP, suramin (P2X and P2Y blocker), PPADS (a P2X blocker), TNP-ATP (P2X 1 and P2X 3 antagonist), and Reactive Blue 2 (a P2Y blocker) on the chemotactic response were also investigated. Rat neutrophil chemotaxis was significantly suppressed by apyrase. fMLP induced rat neutrophil chemotaxis was potentiated by ATP, blocked by suramin, not affected by PPADS or TNP-ATP, and significantly inhibited by RB-2. Western blotting showed that A 3 , P2Y 2 , and P2Y 11 were expressed in rat neutrophils. The chemotactic response of rat neutrophils to fMLP stimulation is potentiated by ATP via P2Y 11 purinoceptors but not P2X purinoceptors or A 3 adenosine receptor, and that the response plays a critical role in host defense and pathogenicity.
Introduction
Neutrophils are the body's first line of defense against invading microorganisms in both innate and humoral immunity. In response to inflammatory stimuli, neutrophils migrate from the circulating blood to infected tissues and protect the host by phagocytizing and killing pathogens (1, 2) . A prominent feature of neutrophil activation is acquisition of the ability to migrate toward infected or compromised tissues by following the concentration gradient of chemotactic substances that are released from bacteria and inflamed tissues. Chemotaxis is a process that involves a gradient field, cell polarization within the gradient field, and finally directed migration forward the source of the chemoattractant (3, 4) . In addition, chemotaxis serves to induce a rapid accumulation of neutrophils at the affected site in order to eliminate the invading pathogens by means of degranulation and pathogocytosis (5) .
A bacterial peptide, N-formyl-methionyl-leucylphenylalanine (fMLP), identified as a potent leukocyte chemoattractant, binds to receptors on the neutrophil outer membrane, thereby activating these cells through a G-protein-coupled pathway (6, 7) . ATP and adenosine modulate neutrophil functions, including chemotaxis (8, 9) . In addition, growing evidence shows that ATP is one of the most important extracellular nucleotides that are rapidly released by cells during inflammatory responses (10, 11) . ATP can be hydrolyzed by ecto-ATPases to generate adenosine; four receptor subtypes have been identified: A 1 , A 2A , A 2B , and A 3 (12) . Receptors mediating responses to ATP have been characterized as P2 purinoceptors and are subdivided into two major classes that include the ion channel P2X purinoceptors and G-protein-coupled P2Y purinoceptors (12) . Each class comprises a number of pharmacologically and genetically distinct subtypes (13) . Furthermore, ATP enhances neutrophil adhesion and extravasation (10, 14) , and also chemotaxis, via the P2Y 2 purinoceptor and A 3 adenosine receptor, in human neutrophils (15 -17) . However, the presence of functional P2 purinoceptors in rat neutrophils has never been shown, and their contribution to neutrophil migration has never been investigated.
We hypothesized that ATP, activation of purinoceptors, and A 3 adenosine receptors play critical roles in the signal mechanisms that control cell orientation and direct the migration of rat neutrophils in response to fMLP as a chemoattractant. We investigated these concepts using image data generated with an EZ-TAXIScan apparatus.
Materials and Methods

Preparation of rat neutrophils
Male Wistar rats weighing 250 -300 g were housed in wire-mesh cages in air-conditioned rooms with a 12-h light-dark cycle at a temperature of 22°C ± 2°C and a relative humidity of 55% ± 15%. They were given ad libitum access to a commercial standard laboratory chow and tap water. The rats were injected intraperitoneally with 25 -30 ml of a 6.0% colloidal suspension of casein. Eighteen hours later, all the animals were killed, and peritoneal exudate cells were collected from their peritoneal cavities (18) . The acquired cells were centrifuged at 800 × g for 10 min at 4°C, and the residual pellet was suspended in 5 ml of ice cold hypotonic buffer (0.15 M NH 4 Cl, 1 mM KHCO 3 , and 1 mM EDTA) and placed on ice for 10 s to lyse contaminating erythrocytes. The neutrophils were pelleted by centrifugation (800 × g for 10 min) and washed twice with 5 ml of phosphate-buffered saline (PBS). The final cell preparation contained 95% viable neutrophils and was used as rat neutrophils for the chemotaxis assay. All animal care and experimental procedures were performed in accordance with the Guidelines for Experimental Animals of Asahi University, and maximum effort was made to minimize animal suffering and reduce the number of animals used.
Chemotaxis assay using EZ-TAXIScan
Screening for rat neutrophil chemotaxis was performed using an EZ-TAXIScan chemotaxis apparatus (19, 20) in which a stable chemoattractant gradient was formed in a 260-μm-wide channel. Images of neutrophils undergoing chemotaxis in response to a chemoattractant were obtained at time-lapse intervals using an EZ-TAXIScan equipped with a six-channel chamber and saved digitally on a computer. The six-channel chamber consists of an etched silicon substrate and a flat glass plate, which together form two compartments with a 4-μm-deep microchannel. A stable concentration gradient of chemoattractant can be reproducibly formed and maintained throughout the microchannel without medium flow. The neutrophils were stimulated by adding fMLP (10 nM) to one hole while treated cells were placed in a contra-hole of the microchannel. Migration of rat neutrophils toward the high concentration of each sample was recorded using a CCD camera to capture time-lapse images every 60 s for 120 min at (25°C) with the EZ-TAXIScan apparatus ( Fig. 1: A -C) . Sequential files and superimposed images of chemotaxing cells were processed using Motic Image Plus software (Shimadzu, Kyoto). Viable cells were assessed in terms of the migration speed, straightness, and directionality of cell movement (21) . Migration speed was defined as a cell's centroid movement (μm/min) along the total path (21) . Directionality was defined as the cosine θ of the angle formed by the line between the cells' starting point and the source of the chemoattractant in the chamber and the line from the cells' starting point to their ending point (21) . Finally, straightness was defined as the net path length divided by the total path length (21) . Cells moving in a straight line have a directionality of 1.0. To obtain the maximum effects of each drug in the primary chemotaxis screening, we treated neutrophils with each inhibitor at a concentration equivalent to 10 times its IC 50 .
Analysis of mRNA expression
Total RNA was extracted from rat brain as a positive control for detecting the presence of P2X purinoceptor gene mRNA by RT-PCR. Total RNA was also extracted from highly pure populations of neutrophils using the TRIzol reagent in accordance with the manufacturer's instructions (Invitrogen, Carlsbad, CA, USA). cDNA was generated from 1 μg of total RNA using Superscript II reverse transcriptase (Invitrogen) and random primers (Invitrogen).
PCR was performed using Taq DNA polymerase ( Invitrogen). Primers for rat P2X purinoceptors were designed based on the published sequence data. The primers (forward, reverse) used were as follows: P2X 1 : ACGGGGACAGCTCCTTTGTA, ATGCCACCTTCT GGGTTCTC (predicted size = 90 bp), P2X 2 : GTTCC CTGCCATCTCCTTTC, CCTAACTTGGGGTCCCT GAA (predicted size = 97 bp), P2X 3 GCAGGTGATTCCAGACACGA, AACGACAAGGC AGCAGAGTG (predicted size = 90 bp), and M: Ladder DNA marker (predicted size = 100 bp). All primers were purchased from Invitrogen. The PCR products were resolved by electrophoresis on 1.5% agarose gels and stained with ethidium bromide (0.5 μg/ml). The gels were exposed to a UV transilluminator (Fotodyne, New Berlin, WI, USA). Image analysis and quantification were performed using Image Saver HR (Sony, Tokyo).
Western blotting analysis
Aliquots of neutrophil extracts (50 μg protein) were mixed with an equal volume of 2 × sodium dodecyl sulfate (SDS) sample buffer (100 mM Tris-HCl, pH 6.8, containing 4% β-mercaptoethanol, 2% SDS, 20% glycerol, and 0.05% bromophenol blue) and boiled for 5 min. The mixtures were then subjected to SDS-polyacrylamide gel electrophoresis (SDS-PAGE) in a 10% gel. The separated proteins were blotted onto a polyvinylidene fluoride (PVDF) membrane. Then each target protein on the membrane was detected by probing with a specific primary antibody, followed by a species-specific secondary antibody conjugated with horseradish peroxidase and staining by the NBT/H 2 O 2 method. Band intensities were measured by computer analysis using Image J (NIH) software.
Materials
The following solutions and drugs have been used in the present study. Modified RPMI-1640 medium was purchased from Sigma Chemical (St. Louis, MO, USA).
amino]-9,10-dihydro-9,10-dioxo-2-anthracene sulphonic acid (Reactive Blue 2, RB-2) was purchased from Wako Pure Chemicals (Osaka). 8,8′-[Carbonylbis[imino-3,1-phenylenecarbonylimino (4-fluoro-3,1-phenylene) carbonylimino]]bis-1,3,5-naphthalenetrisulfonic acid hexasodium salt (NF157) and pyridoxal phosphate-6-azophenyl-2′,4′-disulphonic acid (PPADS) were purchased from Tocris Bioscience (Bristol, UK). Adenosine 5′-triphosphate disodium salt (ATP), 2′,3′-O-(2,4,6-trinitrophenyl) adenosine 5′-triphosphate (TNP-ATP), adenosine 5′-diphosphatase and adenosine 5′-triphosphatase (apyrase), 3-ethyl-5-benzyl-2-methyl-4-phenylethynyl-6-phenyl-1,4-(±)-dihydropyridine-3,5-dicarboxylate (MRS1191) and suramin sodium were obtained from Sigma Chemical. MRS1191 was dissolved in dimethyl sulfoxide. The following antibodies were used: anti-P2Y 11 purinoceptor (Enzo Life Sciences, Farmingdale, NY, USA) and anti-A 3 adenosine receptor and anti-P2Y 2 purinoceptor (Alomone Labs, Jerusalem, Israel). All other drugs were dissolved in distilled water.
Results
Effects of exogenous ATP on neutrophil chemotaxis
Extracellular ATP and adenosine modulate human neutrophil functions, including chemotaxis (8, 9) . To our The EZ-TAXIScan experiments were carried out using fMLP added to one hole, whereas other drugs were added to the contral hole with neutrophils.
knowledge, we are the first to investigate whether extracellular ATP plays a role in fMLP-induced neutrophil chemotaxis using a rat model. We examined the effect of apyrase, an enzyme that hydrolyzes nucleotides, on rat neutrophil chemotaxis. Apyrase (10 U/ml) significantly inhibited neutrophil chemotaxis ( Fig. 2: A -C). Exogenous ATP (10 μM) potently enhanced the chemotactic responses of rat neutrophils stimulated with fMLP ( Fig.  3 : A -C and Supplementary movies 1 and 2: available in the online version only). In addition, to confirm the role of ATP in the process of neutrophil chemotaxis stimulated with fMLP, suramin was employed as a non-specific purinoceptor antagonist. Suramin (50 μM) significantly inhibited neutrophil chemotaxis (Fig. 4: A -C) . These speed Fig. 2 . Effect of apyrase on rat neutrophil chemotaxis induction by fMLP. Neutrophils were preincubated with apyrase (10 U/ml) for 30 min. Apyrase significantly inhibited chemotaxis of neutrophils stimulated with fMLP. Bar graphs show the A) neutrophil migration speed (μm/min), B) directionality (Cos θ), and C) straightness as the mean ± S.E.M. for 6 or 7 animals per group. **P < 0.01 against the control, in which neutrophils were treated only with fMLP (10 nM). drugs did not show any cytotoxic effects on neutrophil viability (data not shown).
Effects of PPADS, TNP-ATP, and RB-2 on neutrophil chemotaxis
It is well established that the action of ATP is mediated through two subtypes of purinoceptors, P2X and P2Y. Therefore, the following experiments were performed to elucidate the receptor subtype(s) through which ATP enhances neutrophil chemotaxis in response to fMLP stimulation. An antagonist of P2X purinoceptor, PPADS (100 μM), and a selective P2X 1 and P2X 3 antagonist, TNP-ATP (100 μM), had no effect on the neutrophil chemotaxis (Fig. 5: A -C) . In contrast, the P2Y puri- noceptor blocker RB-2 significantly inhibited neutrophil migration at 50 μM, implying that P2Y purinoceptors are involved in neutrophil chemotaxis (Fig. 5: A -C) . RB-2 showed no cytotoxic effect on neutrophil viability (data not shown).
Rat neutrophils have functional P2Y 11 channels
EZ-TAXIScan assay was carried out to study the functionality of the P2Y 11 G-protein-coupled receptors. Ullmann et al. (22) have shown that the NF157 have an IC 50 of approximately 0.5 μM at the P2Y 11 purinoceptor and is highly selective for P2Y 11 over all P2X and P2Y purinoceptors. Application of the P2Y 11 -selective antagonist NF157 (0.5 μM) significantly inhibited the chemotaxis of rat neutrophils (Fig. 6 : A -C and Supplementary movie 3: available in the online version only). On the other hand, neutrophils pretreated with an A 3 adenosine receptor-selective antagonist, MRS1191 (10 μM), did not affect the chemotactic response of cells stimulated with fMLP (data not shown). Western blotting analysis revealed that the P2Y 2 and P2Y 11 protein levels in rat neutrophils were about 42 and 40 kDa, respectively. In addition, adenosine A 3 protein was detected at 66 kDa (Fig. 7C) . Collectively, these results suggest that P2Y 11 purinoceptors play an essential role in regulating neutrophil chemotaxis.
Identification of purinoceptor mRNA in rat neutrophils by RT-PCR
ATP purinoceptor gene expression in rat neutrophils was evaluated by detecting the mRNA of each purinoceptor gene with the RT-PCR technique. Amplified products of P2X [1] [2] [3] [4] [5] [6] [7] were observed in appropriate amounts when homogenized rat brain was used as the positive control for RT-PCR (Fig. 7: A, B) .
Discussion
This work using time-lapse images generated with a novel chemotaxis assay apparatus, EZ-TAXIScan, found that various parameters quantified during the process of fMLP-induced rat neutrophil migration were associated with activation of P2 purinoceptors, most likely P2Y 11 purinoceptors.
Fredholm (8) and Chen et al. (9) demonstrated that endogenous ATP and adenosine modulate neutrophil functions, including chemotaxis. In this study, we used a rat neutrophil model and fMLP as a chemoattractant to examine how exogenous ATP activates purinoceptors and A 3 adenosine receptors as key steps in the signal cascade that controls neutrophil migration. Our major findings were that i) apyrase significantly inhibited neutrophil chemotaxis induced by fMLP; ii) ATP enhanced the chemotactic response of rat neutrophils; iii) the neutrophil chemotaxis response was significantly inhibited by suramin, a non-specific purinoceptor antagonist, and by RB-2, a P2Y purinoceptor blocker; iv) blockade of P2X purinoceptors with PPADS and TNP-ATP did not affect neutrophil chemotaxis; v) the neutrophil chemotactic response was significantly inhibited by a P2Y 11 purinoceptor-selective antagonist (NF157); vi) western blotting analysis detected expression of the proteins for A 3 receptor and P2Y 2 and P2Y 11 purinoceptors; and vii) P2X purinoceptor subtypes were expressed in rat neutrophils. These findings demonstrate, for the first time, that ATP enhanced the chemotactic response of rat neutrophils via P2Y 11 purinoceptors, but not P2X purinoceptors or A 3 adenosine receptor.
Apyrase inhibited fMLP-induced neutrophil chemotaxis, implying that fMLP-induced responses require ATP. Exogenous ATP enhanced neutrophil chemotaxis (Fig. 2) , but the degradative effect of ectonucleotidase on ATP in vivo remains poorly understood. In human neutrophils, A 3 adenosine receptors regulate migration speed (15) . On other hand, activation of A 3 receptors inhibited chemotaxis of mouse neutrophils (23) . These variations reflect specific species differences and receptor functions (24) . fMLP chemoattractant stimulation of neutrophils causes release of ATP at the leading edge. The released ATP activates P2Y 2 and A 3 adenosine receptors via ectonucleoside triphosphate diphosphohydrolase 1 and promotes cell migration toward the chemotactic source (25) . In addition, Chen et al. (15) reported that MRS1191 inhibited human neutrophil chemotaxis via A 3 receptors. However, our findings suggest that this is not the case in the rat, since addition of the same selective A 3 adenosinereceptor antagonist (MRS1191) failed to inhibit neutrophil chemotaxis, implying that A 3 adenosine receptors are not involved in rat neutrophil chemotaxis.
Some studies show that P2Y 2 purinoceptors are expressed in human neutrophils and are also important for neutrophil migration in vitro (15, 17) . Moreover, immunostaining showed that P2Y 2 purinoceptors are not concentrated at the leading edge of human neutrophils (15) . Indeed, fMLP-induced rat neutrophil migration was significantly inhibited by a non-specific purinoceptor antagonist, suramin (Fig. 3) , and a P2Y purinoceptor blocker, RB-2 (Fig. 4) . Even today, there is no selective antagonist for P2Y 2 , and it has therefore not been possible to definitively test this purinoceptor for a role in neutrophil migration. Therefore, no conclusions can be drawn regarding whether P2Y 2 plays a role in rat neutrophil migration or even if it exists in rat neutrophils.
Our RT-PCR analysis detected P2X purinoceptors (P2X 1 , P2X 4 , P2X 5 , and P2X 7 ) in rat neutrophils (Fig.  7B) . It is generally accepted that P2X purinoceptors are highly sensitive to PPADS (26) . Moreover, Virginio et al. (27) demonstrated that TNP-ATP was a potent, selective antagonist for P2X 1 and P2X 3 purinoceptors. Our data in Fig. 4 showed insensitivity of ligand-gated ion channel purinoceptors to pharmacological blockade. There were no significant changes in neutrophil migration, indicating that P2X purinoceptors may not be responsible for rat neutrophil chemotaxis.
Western blotting showed expression of P2Y 11 purinoceptors (Fig. 6) . To further define the P2Y 11 purinoceptors involved, we tested a selective antagonist of P2Y 11 (NF157) for its effect on fMLP-induced neutrophil chemotaxis. Moreschi RT-PCR analysis of mRNA expression for purinoceptors in rat brain and rat neutrophils having functional P2Y11 channels. Expression of P2 purinoceptors by rat neutrophils. A) PCR was performed for each of the P2X purinoceptors according to the protocols described in Materials and Methods, and bands of the appropriate sizes were identified as indicated. Total rat brain was used as the positive control containing the purinoceptor subtype cDNA. B) The studies were repeated using samples of cDNA from highly purified rat neutrophils. The neutrophils did not express P2X2, P2X3, or P2X6 purinoceptors. Similar results were obtained in 5 independent experiments. M: 100-bp DNA ladder size marker. C) Representative western blots for rats (n = 4 rats). Western blot detection of A3 adenosine receptor and P2Y2 and P2Y11 purinoceptor proteins in rat neutrophils. The A3 adenosine receptor and the P2Y2 and P2Y11 purinoceptors showed the expected protein with a molecular mass of 66, 42, and 40 KDa, respectively.
previously demonstrated that NF157 inhibited P2Y 11 mediated neutrophil chemotaxis and apoptosis. Our test corroborated that, since 0.5 μM NF157 significantly inhibited neutrophil migration (Fig. 5) . Thus, P2Y 11 purinoceptors appear to play a key role in regulating rat neutrophil chemotaxis by controlling fMLP-induced cell migration.
In conclusion, this study provides the first evidence that ATP enhances the chemotaxis response in rat neutrophils via the P2Y 11 G-protein-coupled receptor and may be potentially useful for treatments against inflammatory diseases.
